Rick Bartram
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Richard B. Bartram worked at PricewaterhouseCoopers LLP from 2005 to 2013 as an Assurance Manager.
From 2013 to 2022, worked at Esperion Therapeutics, Inc., serving as Vice President-Finance from 2015 to 2018.
From 2022 to 2026, worked at MBX Biosciences, Inc. as Chief Financial Officer.
Attended Michigan State University for undergraduate and graduate degrees.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/04/2026 | 48.757 ( 0,1 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| MBX BIOSCIENCES, INC. | Director Financiero/CFO | 15/05/2026 |
| ESPERION THERAPEUTICS, INC. | Director Financiero/CFO | 08/04/2022 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01/02/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.